A phase II trial using multiple cycles of high dose sequential carboplatin, paclitaxel and topotecan with peripheral blood stem cell (PBSC) support as initial chemotherapy in patients with optimally debulked stage III ovarian carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cyclophosphamide; Filgrastim; Paclitaxel; Topotecan
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 09 Aug 2017 Biomarkers information updated
- 10 Apr 2013 Actual end date changed from Mar 2010 to Jan 2007 as reported by ClinicalTrials.gov.
- 10 Apr 2013 Status changed from completed to discontinued reported by ClinicalTrials.gov record.